Mj. Eppinger et al., REGULATORY EFFECTS OF INTERLEUKIN-10 ON LUNG ISCHEMIA-REPERFUSION INJURY, Journal of thoracic and cardiovascular surgery, 112(5), 1996, pp. 1301-1305
Objective: Interleukin-10, a cytokine with antiinflammatory activities
, was studied to determine its effects on development of early lung re
perfusion injury, Methods: Adult male rats underwent 90 minutes of lef
t lung ischemia followed by 4 hours of reperfusion, Time-matched sham-
operated control rats underwent hilar dissection but not lung ischemia
, Lung injury was measured by vascular permeability to bovine serum al
bumin tagged with iodine 125, To evaluate the effect of exogenous inte
rleukin-10, additional animals received interleukin-10 intravenously b
efore ischemia, To assess the role of endogenous interleukin-10, anima
ls received rabbit antimouse interleukin-10 immunoglobin G (or preimmu
ne rabbit immunoglobin G) before ischemia, Results: Compared with sham
control rats, ischemia-reperfusion control rats demonstrated signific
antly more lung injury, Animals receiving interleukin-10 had significa
ntly less lung injury than did ischemia-reperfusion control rats, Anim
als receiving antiinterleukin-10 had significantly more lung injury th
an did animals receiving preimmune immunoglobin G, Alveolar macrophage
s from animals after 90 minutes of lung ischemia produced more tumor n
ecrosis factor-alpha in culture than did unstimulated macrophages; thi
s production was reduced significantly by the addition of interleukin-
10 to the culture medium, Conclusion: Endogenous interleukin-10 has a
protective effect against early lung reperfusion injury, and interleuk
in-10 administration can reduce lung reperfusion injury, perhaps in pa
rt through its ability to reduce production by alveolar macrophages of
tumor necrosis factor-alpha, a known proinflammatory cytokine.